Compare ALEMBIC with Unichem Lab - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC vs UNICHEM LAB - Comparison Results

ALEMBIC     Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC UNICHEM LAB ALEMBIC/
UNICHEM LAB
 
P/E (TTM) x 60.4 -40.3 - View Chart
P/BV x 5.2 1.0 526.1% View Chart
Dividend Yield % 0.2 1.4 14.0%  

Financials

 ALEMBIC   UNICHEM LAB
EQUITY SHARE DATA
    ALEMBIC
Mar-18
UNICHEM LAB
Mar-19
ALEMBIC/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs72292 24.7%   
Low Rs34182 18.6%   
Sales per share (Unadj.) Rs4.7167.7 2.8%  
Earnings per share (Unadj.) Rs6.1-3.6 -168.1%  
Cash flow per share (Unadj.) Rs6.25.9 105.1%  
Dividends per share (Unadj.) Rs0.204.00 5.0%  
Dividend yield (eoy) %0.41.7 22.4%  
Book value per share (Unadj.) Rs40.7372.3 10.9%  
Shares outstanding (eoy) m267.0370.38 379.4%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x11.31.4 796.9%   
Avg P/E ratio x8.7-65.3 -13.3%  
P/CF ratio (eoy) x8.539.9 21.3%  
Price / Book Value ratio x1.30.6 204.5%  
Dividend payout %3.3-110.2 -3.0%   
Avg Mkt Cap Rs m14,13916,680 84.8%   
No. of employees `000NA2.6 0.0%   
Total wages/salary Rs m2072,393 8.7%   
Avg. sales/employee Rs ThNM4,535.2-  
Avg. wages/employee Rs ThNM919.8-  
Avg. net profit/employee Rs ThNM-98.2-  
INCOME DATA
Net Sales Rs m1,25511,801 10.6%  
Other income Rs m370984 37.6%   
Total revenues Rs m1,62512,785 12.7%   
Gross profit Rs m111-835 -13.3%  
Depreciation Rs m38674 5.6%   
Interest Rs m275 2.3%   
Profit before tax Rs m442-600 -73.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m1,2121 173,142.9%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m24-343 -7.0%   
Profit after tax Rs m1,630-256 -637.8%  
Gross profit margin %8.9-7.1 -125.1%  
Effective tax rate %5.457.3 9.5%   
Net profit margin %129.8-2.2 -5,996.4%  
BALANCE SHEET DATA
Current assets Rs m1,86720,384 9.2%   
Current liabilities Rs m5915,029 11.8%   
Net working cap to sales %101.6130.1 78.1%  
Current ratio x3.24.1 77.9%  
Inventory Days Days94105 90.0%  
Debtors Days Days74135 54.5%  
Net fixed assets Rs m1,7919,023 19.8%   
Share capital Rs m534141 379.3%   
"Free" reserves Rs m10,32426,058 39.6%   
Net worth Rs m10,85826,199 41.4%   
Long term debt Rs m410-   
Total assets Rs m11,59131,496 36.8%  
Interest coverage x260.9-7.0 -3,740.4%   
Debt to equity ratio x00-  
Sales to assets ratio x0.10.4 28.9%   
Return on assets %14.1-0.6 -2,458.6%  
Return on equity %15.0-1.0 -1,539.1%  
Return on capital %15.2-2.0 -759.7%  
Exports to sales %1.569.4 2.2%   
Imports to sales %21.00-   
Exports (fob) Rs m198,188 0.2%   
Imports (cif) Rs m263NA-   
Fx inflow Rs m198,188 0.2%   
Fx outflow Rs m264596 44.3%   
Net fx Rs m-2447,592 -3.2%   
CASH FLOW
From Operations Rs m236-3,278 -7.2%  
From Investments Rs m-224-2,860 7.8%  
From Financial Activity Rs m-27-24 109.9%  
Net Cashflow Rs m-15-4,690 0.3%  

Share Holding

Indian Promoters % 64.0 50.1 127.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 15.1 1.3%  
FIIs % 9.7 3.0 323.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 31.7 82.3%  
Shareholders   54,701 20,176 271.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC With:   ASTRAZENECA PHARMA  ALEMBIC PHARMA  CADILA HEALTHCARE  NOVARTIS  DR. DATSONS LABS  

Compare ALEMBIC With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends at Record High; Tata Motors and Adani Ports Among Top Nifty Gainers(Closing)

Indian share markets extended gains to the second day today and ended at record-high levels with Nifty ending above 14,600-mark.

Related Views on News

ALEMBIC LTD Announces Quarterly Results (1QFY21); Net Profit Up 3.5% (Quarterly Result Update)

Aug 10, 2020 | Updated on Aug 10, 2020

For the quarter ended June 2020, ALEMBIC LTD has posted a net profit of Rs 21 m (up 3.5% YoY). Sales on the other hand came in at Rs 131 m (down 49.7% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

UNICHEM LAB Announces Quarterly Results (1QFY20); Net Profit Up 102.2% (Quarterly Result Update)

Jul 30, 2019 | Updated on Jul 30, 2019

For the quarter ended June 2019, UNICHEM LAB has posted a net profit of Rs 5 m (up 102.2% YoY). Sales on the other hand came in at Rs 2 bn (up 15.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB 2018-19 Annual Report Analysis (Annual Result Update)

Jul 4, 2019 | Updated on Jul 4, 2019

Here's an analysis of the annual report of UNICHEM LAB for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of UNICHEM LAB. Also includes updates on the valuation of UNICHEM LAB.

UNICHEM LAB Announces Quarterly Results (4QFY19); Net Profit Up 31.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, UNICHEM LAB has posted a net profit of Rs 37 m (up 31.7% YoY). Sales on the other hand came in at Rs 3 bn (up 35.1% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

More Views on News

Most Popular

'Essential' Smallcap Stock Recommendations(Profit Hunter)

Jan 8, 2021

The smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.

Is Nifty Forming a Top(Fast Profits Daily)

Jan 8, 2021

The charts are telling the bulls to be cautious.

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

A Rare Chance to Invest in Potential Multibaggers in 2021(Profit Hunter)

Jan 11, 2021

Our ace stock picker is ready to capitalise on a big growth opportunity.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC SHARE PRICE


Jan 20, 2021 (Close)

TRACK ALEMBIC

  • Track your investment in ALEMBIC with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE ALEMBIC WITH

MARKET STATS